Literature DB >> 18437851

Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.

Nicola Decaro1, Costantina Desario, Gabriella Elia, Vito Martella, Viviana Mari, Antonio Lavazza, Manuela Nardi, Canio Buonavoglia.   

Abstract

An outbreak of canine parvovirus type 2c (CPV-2c) infection in vaccinated adult dogs is reported. The disease occurred in a breeding kennel in Italy and affected 11 dogs aged between 6 months and 2.5 years, that had been repeatedly administered vaccines containing a type 2 (old type) CPV strain. CPV infection was demonstrated in all diseased dogs by an immunochromatographic test. A CPV strain was isolated from the intestinal content of a 20-month-old pregnant Bernese mountain bitch that underwent a fatal outcome. The strain was characterised as CPV-2c by means of real-time PCR assays using minor groove binder probes. The present report provides further concerns about the real efficacy of type 2-based vaccines against the antigenic variants of CPV and stresses the need for developing new vaccines prepared with the variants currently circulating in the dog population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437851

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  42 in total

1.  Misleading results of the MboII-based identification of type 2a canine parvovirus strains from Hungary reacting as type 2c strains.

Authors:  Zoltán Demeter; Elena Alina Palade; Tibor Soós; Attila Farsang; Csaba Jakab; Miklós Rusvai
Journal:  Virus Genes       Date:  2010-08       Impact factor: 2.332

2.  Characterization of the partial VP2 gene region of canine parvoviruses in domestic cats from Turkey.

Authors:  Dilek Muz; T Ciğdem Oğuzoğlu; M Ozkan Timurkan; Hümay Akın
Journal:  Virus Genes       Date:  2011-12-30       Impact factor: 2.332

3.  The genetic evolution of canine parvovirus - A new perspective.

Authors:  Pei Zhou; Weijie Zeng; Xin Zhang; Shoujun Li
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

4.  WSAVA Guidelines for the vaccination of dogs and cats.

Authors:  M J Day; M C Horzinek; R D Schultz; R A Squires
Journal:  J Small Anim Pract       Date:  2016-01       Impact factor: 1.522

5.  Genetic analysis and emergence of canine parvovirus type 2c in South Eastern Nigeria.

Authors:  C S Ukwueze; C I Nwosuh; E F Obishakin; B M Anene; R C Ezeokonkwo; O A Owoludun; N C Chima; P D Luka
Journal:  Iran J Vet Res       Date:  2020       Impact factor: 1.376

6.  Evaluation of the antigenic relationships among canine parvovirus type 2 variants.

Authors:  Alessandra Cavalli; Vito Martella; Costantina Desario; Michele Camero; Anna Lucia Bellacicco; Pasquale De Palo; Nicola Decaro; Gabriella Elia; Canio Buonavoglia
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

7.  Molecular characterization of canine parvovirus-2 variants circulating in Tunisia.

Authors:  Leila Touihri; Imen Bouzid; Rahma Daoud; Costantina Desario; Amel Founa El Goulli; Nicola Decaro; Abderrazak Ghorbel; Canio Buonavoglia; Chokri Bahloul
Journal:  Virus Genes       Date:  2008-12-28       Impact factor: 2.332

8.  The detection of canine parvovirus type 2c of Asian origin in dogs in Romania evidenced its progressive worldwide diffusion.

Authors:  Andrea Balboni; Mihaela Niculae; Serena Di Vito; Lorenza Urbani; Alessia Terrusi; Cosmin Muresan; Mara Battilani
Journal:  BMC Vet Res       Date:  2021-06-05       Impact factor: 2.741

9.  Genetic complexity and multiple infections with more Parvovirus species in naturally infected cats.

Authors:  Mara Battilani; Andrea Balboni; Martina Ustulin; Massimo Giunti; Alessandra Scagliarini; Santino Prosperi
Journal:  Vet Res       Date:  2011-03-02       Impact factor: 3.683

10.  Identification of canine parvovirus with the Q370R point mutation in the VP2 gene from a giant panda (Ailuropoda melanoleuca).

Authors:  Ling Guo; Shao-lin Yang; Shi-jie Chen; Zhihe Zhang; Chengdong Wang; Rong Hou; Yupeng Ren; Xintian Wen; Sanjie Cao; Wanzhu Guo; Zhongxiang Hao; Zifang Quan; Manli Zhang; Qi-gui Yan
Journal:  Virol J       Date:  2013-05-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.